Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases

E-ISSN： 2212-389x|3|2|138-151

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.3, Iss.2, 2008-05, pp. : 138-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)

Current Signal Transduction Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 246-256

Bentham Science Publishers

Access to resources Recommend Favorite

Mutant IDH1 inhibits PI3K/Akt signaling in human glioma

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2440-2447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Resveratrol exerts growth inhibitory effects on human SZ95 sebocytes through the inactivation of the PI3-K/Akt pathway

International Journal of Molecular Medicine, Vol. 35, Iss. 4, 2015-01 ,pp. : 1042-1050

Spandidos Publications

Access to resources Recommend Favorite

PI3K/AKT pathway activation in bladder carcinogenesis

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : 1776-1784

John Wiley & Sons Inc

Access to resources Recommend Favorite

ERK, PKC and PI3K/Akt Pathways Mediate Extracellular ATP and Adenosine-Induced Proliferation of U138-MG Human Glioma Cell Line

Oncology, Vol. 67, Iss. 5-6, 2005-02 ,pp. : 450-459

Karger

Access to resources Recommend Favorite